V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002744 | 240005379 | 1.86 | 79 | Adjuvant (A) | 2016-12-19 | 2016-12-21 | CLADRIBINE | 02 | N | CNS HGG TEMOZOLOMIDE MAINTENANCE | 101719386 |
| 240002746 | 240005381 | null | null | null | null | 2019-11-23 | Venetoclax | null | null | CYTARABINE + DAUNORUBICIN | 101093915 |
| 240002748 | 240005383 | 1.8 | 64.4 | null | 2017-07-02 | 2017-07-03 | Paclitaxel 7 day | N | null | AML MYECHILD 01 IT CYT | 101382170 |
| 240002750 | 240005385 | 1.7 | 17.3 | null | 2018-11-18 | 2018-11-27 | AML MyeChild 01 IT Cyt | 02 | null | AML MYECHILD 01 HD ARAC | 100085230 |
| 240002752 | 240005387 | 1.8 | 59.6 | null | 2019-05-31 | 2019-05-31 | Venetoclax | 02 | null | IBRUTINIB | 101242258 |
| 240002753 | 240005388 | 1.65 | 78.1 | null | null | 2017-10-26 | CNS LGG Bevacizumab & Irinotecan | N | null | TRANSPLANT ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | 101488863 |
| 240002754 | 240005389 | 1.69 | 57.9 | Curative (C) | null | 2017-06-06 | Methotrexate Intrathecal (any age) | N | N | DA | 100630392 |
| 240002755 | 240005390 | 1.54 | 81.1 | Curative (C) | 2018-12-15 | 2018-12-21 | IBRUTINIB | N | null | R CODOX M | 101564785 |
| 240002756 | 240005391 | 1.67 | 72.9 | 03 | null | 2019-06-25 | DA | null | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 100254163 |
| 240002757 | 240005392 | 1.65 | 100.4 | null | 2016-06-27 | 2017-01-17 | null | N | null | VENETOCLAX | 101368299 |
| 240002758 | 240005393 | 0 | 0 | Curative (C) | 2018-09-17 | 2019-09-09 | null | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100059680 |
| 240002760 | 240005395 | 1.63 | 22.5 | Curative (C) | 2018-05-30 | 2018-06-02 | DA | 02 | null | UKALL2011 | 101835631 |
| 240002761 | 240005396 | 1.75 | 71.4 | 03 | null | 2017-08-16 | CISPLATIN + GEMCITABINE | 2 | N | UKALL2011 | 101043271 |
| 240002763 | 240005397 | 1.71 | 28.05 | 03 | null | 2017-12-20 | null | N | null | CYTARABINE + DAUNORUBICIN | 100590853 |
| 240002764 | 240005398 | 0 | 0 | 03 | 2016-07-23 | 2016-07-28 | null | 02 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101147990 |
| 240002765 | 240005399 | null | 97.5 | null | 2017-12-14 | 2017-12-14 | null | 02 | null | AML MYECHILD 01 IT CYT | 100969938 |
| 240002766 | 240005400 | 1.74 | 80.5 | null | null | 2019-06-06 | Venetoclax | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100669676 |
| 240002768 | 240005402 | 1.65 | 92.5 | Palliative (P) | 2017-10-14 | 2017-10-14 | null | 02 | N | NOT MATCHED | 100081712 |
| 240002769 | 240005403 | 1.78 | 69.8 | Curative (C) | 2019-09-12 | 2019-09-17 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | CYTARABINE HIGH DOSE | 101138675 |
| 240002771 | 240005405 | 1.7 | null | Curative (C) | 2020-08-03 | 2020-08-18 | null | 02 | N | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 100305241 |
| 240002772 | 240005406 | 1.64 | 102 | null | 2018-12-04 | 2018-12-04 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | TRIPLE INTRATHECAL | 101375285 |
| 240002773 | 240005407 | 0 | 62 | null | null | 2019-10-21 | Melphalan IV High dose | null | null | AML MYECHILD 01 HD ARAC | 101607667 |
| 240002774 | 240005408 | 1.43 | 28.4 | null | 2019-09-23 | 2019-09-30 | DA 3+8 | 01 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100612568 |
| 240002776 | 240005410 | 1.53 | 62 | Curative (C) | 2016-07-11 | 2016-07-18 | AML16 DA 3+10 | 02 | N | BUSULFAN | 100573657 |
| 240002777 | 240005411 | 1.54 | 106 | Curative (C) | 2017-05-03 | 2017-05-03 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101584198 |
| 240002778 | 240005412 | null | null | null | 2019-05-11 | 2019-05-11 | null | 02 | null | ANAGRELIDE | 100050790 |
| 240002779 | 240005413 | 1.82 | 80 | Palliative (P) | null | 2018-08-30 | RUXOLITINIB | N | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101576750 |
| 240002780 | 240005414 | 1.43 | 47 | Palliative (P) | null | 2017-04-20 | AML MyeChild 01 FLA-Idarubicin | null | N | BOSUTINIB | 101807235 |
| 240002781 | 240005415 | 1.72 | 77.5 | Curative (C) | 2017-09-10 | 2017-10-23 | null | 2 | null | RUXOLITINIB | 101178629 |
| 240002782 | 240005416 | 0 | 23.05 | null | null | 2017-04-13 | FLAG + Idarubicin | null | null | ALL UKALL2011 MAINTENANCE | 100381221 |
| 240002784 | 240005417 | 0 | null | null | 2019-07-03 | 2019-07-08 | IBRUTINIB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101592296 |
| 240002785 | 240005418 | null | null | null | 2018-03-16 | 2018-03-30 | Acalabrutinib | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100012546 |
| 240002786 | 240005419 | null | 76 | Curative (C) | 2017-06-11 | 2017-07-13 | null | 02 | null | BORTEZOMIB + THALIDOMIDE | 100601343 |
| 240002787 | 240005420 | 1.58 | 78.7 | Curative (C) | 2019-06-18 | 2019-06-28 | AML MyeChild 01 HD AraC | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100469034 |
| 240002788 | 240005421 | 1.77 | 73.5 | 03 | 2017-01-11 | 2017-01-26 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | MERCAPTOPURINE + METHOTREXATE | 101542502 |
| 240002789 | 240005422 | 1.62 | 9 | null | null | 2020-11-19 | Bortezomib + Daratumumab | null | null | STS RHABDO RMS 2005 VIN CYCLO | 100666387 |
| 240002790 | 240005423 | 0 | 42 | null | 2018-09-06 | 2018-10-03 | null | 02 | null | ALL UKALL2011 MAINTENANCE | 101771578 |
| 240002792 | 240005425 | 1.55 | 71.2 | Palliative (P) | 2017-01-28 | 2017-02-02 | Bortezomib +/- Dexamethasone | 02 | null | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101631337 |
| 240002793 | 240005426 | null | null | Curative (C) | 2017-09-13 | 2017-09-18 | Methotrexate intrathecal | Y | null | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + FLUDARABINE | 100254760 |
| 240002794 | 240005427 | 0 | 23.05 | Palliative (P) | null | 2020-08-01 | AML MyeChild 01 FLA-Idarubicin | null | N | ALL INT GDE 2019 MAINTENANCE | 101243678 |
| 240002796 | 240005428 | 0 | 19.4 | Curative (C) | null | 2017-06-28 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | N | null | CLADRIBINE | 100390967 |
| 240002799 | 240005430 | 1.78 | 75 | 03 | null | 2018-08-30 | IMATINIB | null | N | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100748689 |
| 240002800 | 240005431 | 1.76 | 0 | Adjuvant (A) | null | 2019-12-29 | IBRUTINIB | null | N | ALL UKALL2011 DEL INT A | 101636520 |
| 240002801 | 240005432 | 1.12 | 98.2 | Curative (C) | 2016-08-20 | 2016-10-08 | Midostaurin | 02 | N | FLAG + IDARUBICIN | 100815906 |
| 240002802 | 240005433 | 0 | 18.7 | Curative (C) | null | 2016-06-14 | Methotrexate intrathecal | null | null | IMATINIB | 100189750 |
| 240002804 | 240005435 | 1.71 | 62.4 | null | null | 2019-08-07 | null | Y | null | VENETOCLAX | 100823128 |
| 240002806 | 240005437 | null | 73.7 | Curative (C) | null | 2019-11-01 | IVE | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100337863 |
| 240002808 | 240005438 | 1.75 | 58.5 | Curative (C) | 2018-10-03 | 2018-10-04 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | null | VENETOCLAX | 100268047 |
| 240002809 | 240005439 | 1.64 | 72.5 | Palliative (P) | 2020-05-07 | 2020-05-07 | DA | 02 | null | IMATINIB | 100400639 |
| 240002811 | 240005441 | 1.73 | 99.9 | null | 2018-05-17 | 2018-05-17 | Venetoclax | 02 | null | DA | 101321394 |